Watchlist Price Alert

Lyra Therapeutics Inc. (LYRA)

NASDAQ: LYRA · Real-Time Price · USD

0.11

-0.00 (-1.35%)

At close: May 02, 2025, 3:59 PM

0.11

1.75%

After-hours: May 02, 2025, 05:55 PM EDT

Lyra Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-93.44M	-62.68M	-55.28M	-43.51M	-22.13M	-16.31M	-6.03M
Depreciation & Amortization	471K	278K	1.07M	1M	95K	27K	82K
Stock-Based Compensation	6.72M	5.89M	5.45M	2.77M	1.81M	244K	406K
Other Working Capital	-4.46M	-5.33M	6.97M	11.57M	-1.22M	2.32M	-55K
Other Non-Cash Items	22.58M	-1.9M	824K	2.42M	-45K	167K	-1.18M
Deferred Income Tax	n/a	n/a	n/a	-2.42M	n/a	n/a	n/a
Change in Working Capital	-6.35M	-4.88M	4.55M	13.92M	-879K	2.11M	79K
Operating Cash Flow	-70.01M	-63.3M	-43.38M	-25.82M	-21.14M	-13.75M	-6.64M
Capital Expenditures	-2.34M	-1.05M	-164K	-3.38M	-1.77M	-211K	-37K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-47.95M	-122.42M	-64.84M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	130.59M	110.89M	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-1	-64.84M	n/a	n/a	n/a	n/a
Investing Cash Flow	80.31M	-12.58M	-65.01M	-3.38M	-1.77M	-211K	-37K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	500K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-287K	-3.55M	-4.24M	359K	-2.58M	-115K	28.71M
Financial Cash Flow	8.53M	65.69M	96.26M	359K	87.7M	-115K	29.21M
Net Cash Flow	18.82M	-10.2M	-12.13M	-28.85M	64.78M	-14.08M	22.54M
Free Cash Flow	-72.35M	-64.35M	-43.55M	-29.2M	-22.92M	-13.96M	-6.68M